Cannabis use in palliative care – an examination of the evidence and the implications for nurses
- 15 August 2010
- journal article
- review article
- Published by Wiley in Journal of Clinical Nursing
- Vol. 19 (17-18), 2454-2462
- https://doi.org/10.1111/j.1365-2702.2010.03274.x
Abstract
Examine the pharmaceutical qualities of cannabis including a historical overview of cannabis use. Discuss the use of cannabis as a clinical intervention for people experiencing palliative care, including those with life-threatening chronic illness such as multiple sclerosis and motor neurone disease [amyotrophic lateral sclerosis] in the UK. The non-medicinal use of cannabis has been well documented in the media. There is a growing scientific literature on the benefits of cannabis in symptom management in cancer care. Service users, nurses and carers need to be aware of the implications for care and treatment if cannabis is being used medicinally. A comprehensive literature review. Literature searches were made of databases from 1996 using the term cannabis and the combination terms of cannabis and palliative care; symptom management; cancer; oncology; chronic illness; motor neurone disease/amyotrophic lateral sclerosis; and multiple sclerosis. Internet material provided for service users searching for information about the medicinal use of cannabis was also examined. The literature on the use of cannabis in health care repeatedly refers to changes for users that may be equated with improvement in quality of life as an outcome of its use. This has led to increased use of cannabis by these service users. However, the cannabis used is usually obtained illegally and can have consequences for those who choose to use it for its therapeutic value and for nurses who are providing care. Questions and dilemmas are raised concerning the role of the nurse when caring and supporting a person making therapeutic use of cannabis.Keywords
This publication has 40 references indexed in Scilit:
- Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind studyBMJ, 2008
- Experience with the Synthetic Cannabinoid Nabilone in Chronic Noncancer PainPain Medicine, 2006
- Cannabis Use in HIV for Pain and Other Medical SymptomsJournal of Pain and Symptom Management, 2005
- Survey of cannabis use in patients with amyotrophic lateral sclerosisAmerican Journal of Hospice and Palliative Medicine®, 2004
- Pharmacokinetics and Pharmacodynamics of CannabinoidsClinical Pharmacokinetics, 2003
- A Dramatic Response to Inhaled Cannabis in a Woman with Central Thalamic Pain and DystoniaJournal of Pain and Symptom Management, 2002
- Cannabis or health?Current Opinion in Psychiatry, 2002
- Pharmacological actions and therapeutic uses of cannabis and cannabinoidsAnaesthesia, 2001
- Marijuana in the management of amyotrophic lateral sclerosisAmerican Journal of Hospice and Palliative Medicine®, 2001
- Marijuana for the Management of Proximal Myotonic MyopathyJournal of Pain and Symptom Management, 2001